Herpes Zoster After COVID Vaccination

Overview

Journal Int J Infect Dis

Publisher Elsevier

Specialty Infectious Diseases

Date 2021 Aug 24

PMID 34428545

Citations 38

Authors

C S van Dam

I Lede

J Schaar

M Al-Dulaimy

R Rosken

M Smits

Affiliations

Soon will be listed here.

Abstract

COVID-19 presents in various ways, but mainly as a pulmonary disease (Marzano, 2020). Skin manifestations have been reported, including reactivation of the varicella-zoster virus (Marzano, 2020). Our case report describes two adults developing herpes zoster after vaccination with tozinameran (the Pfizer-BioNTech COVID-19 mRNA vaccine). A possible cause for this reaction is a transient lymphocytopenia that occurs after the vaccination - similar to that in COVID-19 disease (Mulligan, 2020; Wang, 2020; Qin, 2020; Brabilla, 2020; Wang, 2020; Wei, 2017). In the context of vaccinating older and/or immunocompromised adults, our observations can be the starting point for further evaluation of a possible relationship between COVID-19, COVID vaccines, and herpes zoster.

Citing Articles

Ocular Implications of COVID-19 Infection and Vaccine-Related Adverse Events.

Parmar U, Surico P, Singh R, Musa M, Scarabosio A, Surico G J Pers Med. 2024; 14(8).

PMID: 39201972 PMC: 11355216. DOI: 10.3390/jpm14080780.

Disseminated herpes zoster with varicella encephalitis and pneumonia following ChAdOx1 nCoV-19 (AZD1222) vaccine in an immunocompetent male-a case report.

Gopi R, Stanley W, Surkunda S, Rajagopal S Heliyon. 2024; 10(11):e32248.

PMID: 38947434 PMC: 11214456. DOI: 10.1016/j.heliyon.2024.e32248.

Herpes Zoster Reactivation After COVID-19 Vaccine with Focus on Postherpetic Neuralgia Prevention: A Case Series.

Chrona E, Tsoumani M, Batistaki C Anesth Pain Med. 2024; 13(6):e131366.

PMID: 38721437 PMC: 11078222. DOI: 10.5812/aapm-131366.

Vasculitis-Like Hemorrhagic Herpes Zoster and HIV Infections: An Intricate Association.

Cozma E, Banciu L, Soare C, Gaman M, Voiculescu V Cureus. 2024; 15(12):e50609.

PMID: 38226125 PMC: 10788595. DOI: 10.7759/cureus.50609.

Herpes Zoster and COVID-19 Vaccination: A Narrative Review.

Potestio L, Megna M, Villani A, Cacciapuoti S, Scalvenzi M, Martora F Clin Cosmet Investig Dermatol. 2023; 16:3323-3331.

PMID: 38021418 PMC: 10658959. DOI: 10.2147/CCID.S441898.

References

Bostan E, Yalici-Armagan B . Herpes zoster following inactivated COVID-19 vaccine: A coexistence or coincidence?. J Cosmet Dermatol. 2021; 20(6):1566-1567. DOI: 10.1111/jocd.14035. View

Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao Y . Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis. 2020; 71(15):762-768. PMC: 7108125. DOI: 10.1093/cid/ciaa248. View

Wang Y, Zhu G, Lai W, Zheng Y . Transmission of varicella-zoster-virus (VZV) in family: Calls for attention during COVID-19 outbreak. J Cosmet Dermatol. 2020; 19(12):3166-3167. DOI: 10.1111/jocd.13808. View

Elsaie M, Youssef E, Nada H . Herpes zoster might be an indicator for latent COVID 19 infection. Dermatol Ther. 2020; 33(4):e13666. PMC: 7267085. DOI: 10.1111/dth.13666. View

Mulligan M, Lyke K, Kitchin N, Absalon J, Gurtman A, Lockhart S . Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults. Nature. 2020; 586(7830):589-593. DOI: 10.1038/s41586-020-2639-4. View

Gershon A, Breuer J, Cohen J, Cohrs R, Gershon M, Gilden D . Varicella zoster virus infection. Nat Rev Dis Primers. 2016; 1:15016. PMC: 5381807. DOI: 10.1038/nrdp.2015.16. View

Saati A, Al-Husayni F, Malibari A, Bogari A, Alharbi M . Herpes Zoster Co-Infection in an Immunocompetent Patient With COVID-19. Cureus. 2020; 12(7):e8998. PMC: 7358933. DOI: 10.7759/cureus.8998. View

Maia C, Marques N, Lucena E, de Rezende L, Martelli D, Martelli-Junior H . Increased number of Herpes Zoster cases in Brazil related to the COVID-19 pandemic. Int J Infect Dis. 2021; 104:732-733. PMC: 7877899. DOI: 10.1016/j.ijid.2021.02.033. View

Wei L, Zhao J, Wu W, Zhang Y, Fu X, Chen L . Decreased absolute numbers of CD3 T cells and CD8 T cells during aging in herpes zoster patients. Sci Rep. 2017; 7(1):15039. PMC: 5678144. DOI: 10.1038/s41598-017-15390-w. View

10.

Furer V, Zisman D, Kibari A, Rimar D, Paran Y, Elkayam O . Herpes zoster following BNT162b2 mRNA COVID-19 vaccination in patients with autoimmune inflammatory rheumatic diseases: a case series. Rheumatology (Oxford). 2021; 60(SI):SI90-SI95. PMC: 8083327. DOI: 10.1093/rheumatology/keab345. View

11.

Kamphuis E, Junt T, Waibler Z, Forster R, Kalinke U . Type I interferons directly regulate lymphocyte recirculation and cause transient blood lymphopenia. Blood. 2006; 108(10):3253-61. DOI: 10.1182/blood-2006-06-027599. View

12.

Wang F, Nie J, Wang H, Zhao Q, Xiong Y, Deng L . Characteristics of Peripheral Lymphocyte Subset Alteration in COVID-19 Pneumonia. J Infect Dis. 2020; 221(11):1762-1769. PMC: 7184346. DOI: 10.1093/infdis/jiaa150. View

13.

Tessas I, Kluger N . Ipsilateral herpes zoster after the first dose of BNT162b2 mRNA COVID-19 vaccine. J Eur Acad Dermatol Venereol. 2021; 35(10):e620-e622. PMC: 8242810. DOI: 10.1111/jdv.17422. View

14.

Marra F, Parhar K, Huang B, Vadlamudi N . Risk Factors for Herpes Zoster Infection: A Meta-Analysis. Open Forum Infect Dis. 2020; 7(1):ofaa005. PMC: 6984676. DOI: 10.1093/ofid/ofaa005. View

15.

Folegatti P, Ewer K, Aley P, Angus B, Becker S, Belij-Rammerstorfer S . Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial. Lancet. 2020; 396(10249):467-478. PMC: 7445431. DOI: 10.1016/S0140-6736(20)31604-4. View

16.

Marzano A, Genovese G, Fabbrocini G, Pigatto P, Monfrecola G, Piraccini B . Varicella-like exanthem as a specific COVID-19-associated skin manifestation: Multicenter case series of 22 patients. J Am Acad Dermatol. 2020; 83(1):280-285. PMC: 7161488. DOI: 10.1016/j.jaad.2020.04.044. View

17.

Recalcati S . Cutaneous manifestations in COVID-19: a first perspective. J Eur Acad Dermatol Venereol. 2020; 34(5):e212-e213. DOI: 10.1111/jdv.16387. View

18.

Dayan R, Peleg R . Herpes zoster - typical and atypical presentations. Postgrad Med. 2017; 129(6):567-571. DOI: 10.1080/00325481.2017.1335574. View

19.

Sahin U, Muik A, Derhovanessian E, Vogler I, Kranz L, Vormehr M . COVID-19 vaccine BNT162b1 elicits human antibody and T1 T cell responses. Nature. 2020; 586(7830):594-599. DOI: 10.1038/s41586-020-2814-7. View

20.

Pona A, Jiwani R, Afriyie F, Labbe J, Cook P, Mao Y . Herpes zoster as a potential complication of coronavirus disease 2019. Dermatol Ther. 2020; 33(6):e13930. PMC: 7361152. DOI: 10.1111/dth.13930. View